Navigation Links
Affitech in Medical Technology

Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies

... OSLO, Norway, April 28 /PRNewswire/ -- affitech AS, the human antibody therapeutics company, annou... libraries. The researchers from Peregrine, affitech and UT Southwestern Medical Center confirmed previ...al Center (Peregrine's academic collaborators) and affitech demonstrated in in vitro studies that immature den...

Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrine's Fully Human Anti-PS Antibody in Prostate Cancer Model

... from UT Southwestern Medical Center in Dallas and affitech A/S reported that similar to bavituximab, the huma...ent and CEO of Peregrine. "Our collaboration with affitech to generate fully human anti-PS antibodies has pro...s developed through Peregrine's collaboration with affitech A/S. The studies were supported in part by a gran...

Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies

...m of scientists from Peregrine Pharmaceuticals and affitech A/S used a fully human anti-PS antibody, PGN635, t...esearchers from UT Southwestern Medical Center and affitech demonstrated the ability of Peregrine's fully huma...e developed through Peregrine's collaboration with affitech A/S. The study by Dr. Huang, et al. was partly sup...

New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models

...VEGF-induced angiogenesis. We look forward to further assessing R84 as a potential anti-angiogenic clinical candidate." Peregrine in association with affitech has filed a patent application for R84 with the United States Patent and Trademark Office to preserve the right to obtain patent protection in the Uni...

Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models

...human antibody R3 used in these studies was developed in collaboration with affitech AS of Norway. These studies were also supported in part by a postdoctoral f...ason B. Fleming, Rolf A. Brekken. UT Southwestern Medical Ctr., Dallas, TX, affitech AS, Oslo, Norway, Peregrine Pharmaceuticals Inc., Tustin, CA, UT-MD Anderso...

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

... OSLO, Norway--(BUSINESS WIRE)--Apr 23, 2007 - affitech AS, the human antibody therapeutics company announ...n therapeutic antibody program " Editors notes affitech AS is a privately held human therapeutic antibody ...rrently in development were generated by CBAS(TM). affitech also sells its proprietary Protein L product line ...
Affitech in Biological News

Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies

...m of scientists from Peregrine Pharmaceuticals and affitech A/S used a fully human anti-PS antibody, PGN635, t...esearchers from UT Southwestern Medical Center and affitech demonstrated the ability of Peregrine's fully huma...e developed through Peregrine's collaboration with affitech A/S. The study by Dr. Huang, et al. was partly sup...
Affitech in Biological Technology

Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company

COPENHAGEN and OSLO, March 4 /PRNewswire/ -- Pharmexa A/S and Affitech AS announced today that they have entered into a conditional agreement to merge the two companies by means of a share for share acquisition by Pharmexa A/S of the private Norwegian company, Affitech AS. The purpose of the m...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

TUSTIN, Calif. and HORSHOLM, Denmark, July 22 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) and Affitech A/S (Nasdaq OMX: AFFI) today announced that they have entered into a licensing agreement for antibody therapeutic rights under Peregrine's ...

Affitech Acquires Pharmexa's Diabody Technology

... OSLO, Norway, October 28 /PRNewswire/ -- affitech AS, the human therapeutic antibody company, today ...ollows an exclusive license of the diabody IP that affitech obtained in 2007 from Pharmexa to carry out certai...s sub-licensing arrangements with third parties. affitech CEO Martin Welschof commented: "This is a key st...

Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration

... OSLO, September 23 /PRNewswire/ -- affitech AS, the Norwegian human antibody therapeutics comp...ant antibodies against an unnamed oncology target. affitech has successfully used its MBAS (Molecule Based Ant...hof, Ph.D., Chief Executive Officer of Affitech. affitech and Roche entered into this collaboration in 2007 ...

Affitech Appoints Dr. Keith McCullagh as Chairman

... OSLO, Norway, September 9 /PRNewswire/ -- affitech AS, the Norwegian antibody therapeutics company, t...biopharmaceuticals market, but I am confident that affitech will benefit from his leadership and guidance. I w...novative potential new products. I look forward to affitech achieving several competitive commercial goals in ...

Affitech and Omeros Enter Into Antibody Discovery and Development Agreement

...ased clinical-stage biopharmaceutical company, and affitech AS, a Norwegian human antibody therapeutics compan... to advance the development of its MASP-2 program. affitech will apply its expansive human antibody libraries ... at Oxford University. Notes to editors: About affitech AS ...
Other Tags
(Date:7/11/2014)... Volunteers from Scientology Churches and Missions ... drug education lectures, forums and conferences, information stands, sports ... the world. , Drug abuse is an international epidemic. ... abuse of alcohol and illicit drugs costs more than ... productivity and healthcare. , In the face of ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Datalogic brings ... in improving sanitation hospital wide. With their new ... spread of disease, like the devastating MRSA, which claimed ... Gryphon GD4400-HC 2D and the Gryphon GM4400-HC ... barcodes and can even read barcodes off of troublesome ...
(Date:7/11/2014)... U.S. health officials have concluded that it,s highly unlikely ... a safety mishap last month. But, the U.S. ... a moratorium on the transfer of any dangerous germs ... report issued Friday, the CDC outlined several measures the ... doesn,t occur again. Last month, as many as 75 ...
(Date:7/11/2014)... Global enterprises today are shifting towards ... management activities. Managed services offer these global enterprises a ... slowdown resulted into rising operational costs to companies. The ... to be the global market driver for expanding the ... managed services market is estimated to grow from $142.75 ...
(Date:7/11/2014)... (July 10, 2014) Obese and overweight firefighters ... health care providers, according to new research from ... Houston (UTHealth). , National guidelines state that health ... importance of maintaining a healthy weight. Firefighters have ... the leading cause of line-of-duty deaths in firefighters. ...
Breaking Medicine News(10 mins):Health News:Scientologists Taking Action against Drug Abuse 2Health News:Scientologists Taking Action against Drug Abuse 3Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 2Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 3Health News:CDC Issues Tough Report on Anthrax Scare 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4
(Date:7/11/2014)... available in German . ... that uses the refraction of X-rays through a specimen ... with this method are often of much higher quality ... team of Prof. Franz Pfeiffer are particularly interested in ... including X-ray phase-contrast imaging. One main goal is ...
(Date:7/11/2014)... at the National Institute of Standards and Technology ... work more effectively, they often prove that necessity ... the case recently for M. Lorna De Leoz ... growing specialization of glycomics. Glycomics is the study ... that are attached to proteins and lipids and ...
(Date:7/11/2014)... 2014, Shenzhen, China Researchers from Salk Institute for ... first time evaluated the safety and reliability of ... developed a new method, TALEN-HDAdV, which could significantly ... cell (hiPSC). This study published online in ... foundation for stem cell-based gene therapy. , The ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2
Other Contents